🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

8 recruiting trials

for DFNB9

Otoferlin Patient Registry and Natural History Study NCT05946057n/a1 site📍 Goettigen Tobias Moser · Tests: Molecular genetic testing and audiometry Otoferlin Gene-mediated Hearing Loss Natural History Study NCT05572073n/a10 sites📍 Iowa City📍 Cincinnati📍 Philadelphia Akouos, Inc. · Tests: Natural History Study Auditory Restoration and Outcomes After Gene Therapy and Cochlear Implantation: a PRospective Cohort Analysis (AURORA) NCT06237790n/a6 sites📍 Beijing📍 Zhengzhou📍 Changsha Eye & ENT Hospital of Fudan University A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations NCT05788536Phase 1, Phase 217 sites📍 Los Angeles📍 San Diego📍 Jacksonville Regeneron Pharmaceuticals · Tests: DB-OTO Natural History in Children up to 16 Years With Mild to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes NCT05402813n/a1 site📍 Paris Sensorion · Tests: Pure Tone Audiometry Assessment, Quality of Life Questionnaires Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss NCT05821959Phase 39 sites📍 San Francisco📍 Iowa City📍 Boston Eli Lilly and Company · Tests: AAVAnc80-hOTOF via Akouos Delivery Device, AAVAnc80-hOTOF via Akouos Delivery Device and Precision Delivery Mechanism A Clinical Trial of EHT102 Injection in Pediatric Patients With Biallelic hOTOF Mutations NCT07288580Phase 1, Phase 21 site📍 Shanghai Shanghai Euhearing Therapeutics Co., Ltd · Tests: EHT102 Injection A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss NCT06722170NA2 sites📍 Zhengzhou📍 Shanghai Yilai Shu · Tests: EH002 administration
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy